Literature DB >> 1367698

Growth limitation in hybridoma cell cultures: the role of inhibitory or toxic metabolites.

O W Rønning1, M Schartum, A Winsnes, G Lindberg.   

Abstract

Hybridoma cells usually grow to fairly low cell densities in batch cultures (1-3 x 10(6) cells/ml). The reason for this is either that essential nutritional components of the medium are consumed, or that the cells produce some kind of inhibitory or toxic metabolite. This investigation presents evidence for the latter. Spent medium from cultures of hybridoma cells did not support growth of cells at lower cell densities (1-3 x 10(5) cells/ml). The ability to support cell growth could not be restored by adding additional serum, energy sources (glucose, pyruvate) or L-glutamine. Furthermore, the consumption of amino acids could not account for this growth inhibition. On the contrary, the spent medium contained a substance that inhibited cell growth. This substance or metabolite was found in a fraction eluted from a gel filtration column when spent medium was applied to the column. This substance was found in the spent medium from all hybridoma and myeloma cell lines that were tested. The molecular weight of the substance was about 5 kD. Spent medium from two hybridoma cell lines also contained a substance that was eluted in the same fraction as albumin (67 kD). It is likely that this (or these) substance(s) is responsible for the growth limitation in hybridoma cell cultures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367698     DOI: 10.1007/bf00135634

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  10 in total

1.  Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation.

Authors:  M J Comer; M J Kearns; J Wahl; M Munster; T Lorenz; B Szperalski; S Koch; U Behrendt; H Brunner
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

Review 2.  Hybridoma growth limitations: the roles of energy metabolism and ammonia production.

Authors:  M Newland; P F Greenfield; S Reid
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

3.  An ELISA-method using magnetic beads as solid phase for rapid quantitation of mouse and human immunoglobulins.

Authors:  O W Rønning; A C Christophersen
Journal:  Hybridoma       Date:  1991-10

4.  Mouse x human heterohybridomas as fusion partners with human B cell tumors.

Authors:  W L Carroll; K Thielemans; J Dilley; R Levy
Journal:  J Immunol Methods       Date:  1986-05-01       Impact factor: 2.303

5.  Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles.

Authors:  A Lund; A L Hellemann; F Vartdal
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Large-scale production of monoclonal antibodies in dialysis tubing.

Authors:  E Sjögren-Jansson; S Jeansson
Journal:  J Immunol Methods       Date:  1985-11-28       Impact factor: 2.303

8.  Variation of amino acid concentrations in the medium of HU β-IFN and HU IL-2 producing cell lines.

Authors:  R Wagner; T Ryll; H Krafft; J Lehmann
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

9.  Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells.

Authors:  M W Glacken; R J Fleischaker; A J Sinskey
Journal:  Biotechnol Bioeng       Date:  1986-09       Impact factor: 4.530

10.  Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.

Authors:  G Kvalheim; O Fodstad; A Pihl; K Nustad; A Pharo; J Ugelstad; S Funderud
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

  10 in total
  5 in total

1.  Optimal medium use for continuous high density perfusion processes.

Authors:  H Büntemeyer; C Wallerius; J Lehmann
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Growth study of lactate and ammonia double-resistant clones of HL-60 cells.

Authors:  B Schumpp; E J Schlaeger
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Effects on growth behavior in continuous hybridoma cell cultures: The role of viral contamination.

Authors:  A Hawerkamp; D Lütkemeyer; F Gudermann; A Falkenhain; H Büntemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

4.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Authors:  R Heidemann; C Zhang; H Qi; J Larrick Rule; C Rozales; S Park; S Chuppa; M Ray; J Michaels; K Konstantinov; D Naveh
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

5.  Increase of hybridoma productivity using an original dialysis culture system.

Authors:  B Mathiot; A Perani; D Dumas; M Maugras; J Didelon; J F Stoltz
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.